Literature DB >> 3342461

Membrane transport changes in an adriamycin-resistant murine leukemia cell line and in its sensitive parental cell line.

R Bose1, H Y Lam.   

Abstract

Multidrug resistance in cancer chemotherapy occurs when cells develop resistance towards structurally and functionally unrelated drugs. It is speculated that alteration of some fundamental process(es) in the cells leads to the development of multidrug resistance. The sodium pump activity of murine leukemia cell lines P388/S (sensitive) and P388/ADR (resistant) was measured and found to be different in the two cell lines. The rate of sodium pumping, i.e., the ouabain-sensitive rubidium uptake, was consistently lower in the resistant cells compared to their parental controls. Uptake of adriamycin was lower in the resistant cells. Depolarizing the cells with potassium chloride or by inhibiting the pump with ouabain increased the adriamycin uptake in the sensitive cells but not in the resistant cells. Adriamycin did not have any acute effects on the sodium pump activity. It is concluded that the development of drug resistance in cell line P388 is associated with a decrease in sodium pump activity and a lack of depolarization-induced adriamycin uptake; these processes may be causally linked via alterations in cytosolic calcium concentration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342461     DOI: 10.1007/bf00262731

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  24 in total

1.  Uptake and binding of vincristine by murine leukemia cells.

Authors:  W A Bleyer; S A Frisby; V T Oliverio
Journal:  Biochem Pharmacol       Date:  1975-03-01       Impact factor: 5.858

2.  Contact inhibition of division: involvement of the electrical transmembrane potential.

Authors:  C D Cone; M Tongier
Journal:  J Cell Physiol       Date:  1973-12       Impact factor: 6.384

3.  Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.

Authors:  K Dano
Journal:  Biochim Biophys Acta       Date:  1973-10-25

4.  Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.

Authors:  T Tsuruo; H Iida; M Nojiri; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

5.  Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells.

Authors:  T Skovsgaard
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

6.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

Authors:  M Inaba; H Kobayashi; Y Sakurai; R K Johnson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

7.  Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.

Authors:  N Kartner; J R Riordan; V Ling
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

8.  Reversal of resistance to rhodamine 123 in adriamycin-resistant Friend leukemia cells.

Authors:  T J Lampidis; J N Munck; A Krishan; H Tapiero
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

9.  Evidence that a Na+/Ca2+ antiport system regulates murine erythroleukemia cell differentiation.

Authors:  R L Smith; I G Macara; R Levenson; D Housman; L Cantley
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

10.  Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

View more
  3 in total

1.  Increased cation transport in mdr1-gene-expressing K562 cells.

Authors:  T Brismar; A Gruber; C Peterson
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

2.  Reversal of multidrug resistance in murine fibrosarcoma cells by thioxanthene flupentixol.

Authors:  D Fan; G Poste; C Seid; L E Earnest; T Bull; R K Clyne; I J Fidler
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

3.  p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance.

Authors:  Ji Yeon Yang; Seon-Ah Ha; Yun-Sik Yang; Jin Woo Kim
Journal:  BMC Cancer       Date:  2010-07-22       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.